Clinical utility of platinum chromium bare-metal stents in coronary heart disease.
Coronary stents represent a key development for the treatment of obstructive coronary artery disease since the introduction of percutaneous coronary intervention. While drug-eluting stents gained wide acceptance in contemporary percutaneous coronary intervention practice, further developments in bare-metal stents remain crucial for patients who are not candidates for drug-eluting stents, or to improve metallic platforms for drug elution. Initially, stent platforms used biologically inert stainless steel, restricting stent performance due to limitations in flexibility and strut thickness. Later, cobalt chromium stent alloys outperformed steel as the material of choice for stents, allowing latest generation stents to be designed with significantly thinner struts, while maintaining corrosion resistance and radial strength. Most recently, the introduction of the platinum chromium alloy refined stent architecture with thin struts, high radial strength, conformability, and improved radiopacity. This review will provide an overview of the novel platinum chromium bare-metal stent platforms available for coronary intervention. Mechanical properties, clinical utility, and device limitations will be summarized and put into perspective.
Department of Cardiovascular Medicine, University Hospitals Leuven, Leuven, Belgium.
Claudia
C
Jorge
Department of Cardiovascular Medicine, University Hospitals Leuven, Leuven, Belgium ; Department of Cardiovascular Sciences, Katholieke Universiteit Leuven, Leuven, Belgium.
Christophe
C
Dubois
bare metal stent; coronary artery disease; coronary stent alloys